FindTrial
Sign In

Research of the biomarker for the early diagnosis of Graves ophthalmopathy

Research of the biomarker for the early diagnosis of Graves ophthalmopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036402
Enrollment
Unknown
Registered
2020-08-22
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graves ophthalmopathy

Interventions

Case series:Nil

Sponsors

Ruijin Hospital North, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with Graves ophthalmopathy or Graves dieases

Exclusion criteria

Exclusion criteria: patients with systemic disease,including Rheumatic immune disease,diabetes,etc.and orbital inflammatory disease or orbital trauma

Design outcomes

Primary

MeasureTime frame
TRAb;IL-6;—

Secondary

MeasureTime frame
IL-8;TNF-alpha;IGF-1R;—

Countries

China

Contacts

Public ContactHuiping Yao

Ruijin Hospital North, Shanghai Jiao Tong University School of Medicine

dr-yao@13.com+86 18121263259

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026